Therapeutic gene transfer with herpes-based vectors: Studies in Parkinson's disease and motor nerve regeneration

Experimental Neurology

Volumn 184, Issue SUPPL. 1, 2003, Pages 19-24

  Fink, David J ^a,b   Glorioso, Joseph ^c   Mata, Marina ^a,b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d NONE   (United States)

Author keywords

Gene therapy; Herpes simplex; Parkinson's disease; Peripheral nerve; Trauma

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; OXIDOPAMINE; PROTEIN BCL 2; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS VECTOR; MOTOR NERVE; NERVE CELL NECROSIS; NERVE REGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL ROOT; SPINE INJURY; VIRAL GENE THERAPY;

EID: 0242302561     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00358-3     Document Type: Article

References (41)

1. Adams J.M., Cory S. The Bcl-2 protein family arbiters of cell survival . Science. 281:1998;1322-1326.
2. Airaksinen M.S., Saarma M. The GDNF family signalling, biological functions and therapeutic value . Nat. Rev. Neurosci. 3:2002;383-394.
3. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R.A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
4. Bilang-Bleuel A., Revah F., Colin P., Locquet I., Robert J.J., Mallet J., Horellou P. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA. 94:1997;8818-8823.
5. Bohn M.C., Choi-Lundberg D.L., Davidson B.L., Leranth C., Kozlowski D.A., Smith J.C., O'Banion M.K., Redmond D.E. Jr. Adenovirus-mediated transgene expression in nonhuman primate brain. Hum. Gene. Ther. 10:1999;1175-1184.
6. Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G., Gross F., Yvon E., Nusbaum P., Selz F., Hue C., Certain S., Casanova J.L., Bousso P., Deist F.L., Fischer A. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 288:2000;669-672.
7. Check E. Regulators split on gene therapy as patient shows signs of cancer. Nature. 419:2002;545-546.
8. Choi-Lundberg D.L., Lin Q., Chang Y.-N., Chiang Y.L., Hay C.M., Mohajeri H., Davidson B.L., Bohn M.C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 275:1997;838-841.
9. Choi-Lundberg D.L., Lin Q., Schallert T., Crippens D., Davidson B.L., Chang Y.N., Chiang Y.L., Qian J., Bardwaj L., Bohn M.C. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Exp. Neurol. 154:1998;261-275.
10. DeLuca N.A., McCarthy A.M., Schaffer P.A. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56:1985;558-570.
11. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases structure, activation, substrates, and functions during apoptosis . Annu. Rev. Biochem. 68:1999;383-424.
12. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255.
13. Hobbs W.E. 2nd, DeLuca N.A. Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J. Virol. 73:1999;8245-8255.
14. Honess R.W., Roizman B. Regulation of herpesvirus macromolecular synthesis I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14:1974;8-19.
15. Kearns C.M., Gash D.M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672:1995;104-111.
16. Kirik D., Rosenblad C., Bjorklund A., Mandel R.J. Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system . J. Neurosci. 20:2000;4686-4700.
17. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science. 290:2000;767-773.
18. Krisky D.M., Wolfe D., Goins W.F., Marconi P.C., Ramakrishnan R., Mata M., Rouse R.J., Fink D.J., Glorioso J.C. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther. 5:1998;1593-1603.
19. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:2000;513-519.
20. Lin L.F.H., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons . Science. 260:1993;1130-1132.
21. Mandel R.J., Snyder R.O., Leff S.E. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease. Exp. Neurol. 160:1999;205-214.
22. Mandel R.J., Spratt S.K., Snyder R.O., Leff S.E. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc. Natl. Acad. Sci. USA. 94:1997;14083-14088.
23. Markert J.M., Parker J.N., Gillespie G.Y., Whitley R.J. Genetically engineered human herpes simplex virus in the treatment of brain tumours. Herpes. 8:2001;17-22.
24. Nakai H., Montini E., Fuess S., Storm T.A., Grompe M., Kay M.A. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat. Genet. 34:2003;297-302.
25. Natsume A., Mata M., Goss J.R., Huang S., Wolfe D., Oligino T., Glorioso J.C., Fink D.J. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA induced degeneration. Exp. Neurol. 169:2001;231-238.
26. Natsume A., Mata M., Wolfe D., Oligino T., Goss J., Huang S., Glorioso J., Fink D.J. Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect. J. Neurotrauma. 19:2002;61-68.
27. Natsume, A., Wolfe, D., Hu, J., Huang, S., Puskovic, V., Glorioso, J.C., Fink, D.J., Mata, M., in press. Enhanced functional recovery after proximal nerve root injury by vector-mediated gene transfer. Exp. Neurol.
28. Nutt J.G., Burchiel K.J., Comella C.L., Jankovic J., Lang A.E., Laws E.R. Jr., Lozano A.M., Penn R.D., Simpson R.K. Jr., Stacy M., Wooten G.F. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology. 60:2003;69-73.
29. Ozuer A., Wechuck J.B., Russell B., Wolfe D., Goins W.F., Glorioso J.C., Ataai M.M. Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors. Biotechnol. Prog. 18:2002;476-482.
30. Palfi S., Leventhal L., Chu Y., Ma S.Y., Emborg M., Bakay R., Deglon N., Hantraye P., Aebischer P., Kordower J.H. Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J. Neurosci. 22:2002;4942-4954.
31. Rosenblad C., Kirik D., Bjorklund A. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Exp. Neurol. 161:2000;503-516.
32. Samaniego L.A., Wu N., DeLuca N.A. The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J. Virol. 71:1997;4614-4625.
33. Sauer H., Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine a combined retrograde tracing and immunocytochemical study in the rat . Neuroscience. 59:1994;401-415.
34. Sauer H., Rosenblad C., Bjorklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA. 92:1995;8935-8939.
35. Tomac A., Lindqvist E., Lin L.F., Ogren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
36. Treanor J.J., Goodman L., de Sauvage F., Stone D.M., Poulsen K.T., Beck C.D., Gray C., Armanini M.P., Pollock R.A., Hefti F., Phillips H.S., Goddard A., Moore M.W., Buj-Bello A., Davies A.M., Asai N., Takahashi M., Vandlen R., Henderson C.E., Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature. 382:1996;80-83.
37. Trupp M., Arenas E., Fainzilber M., Nilsson A.S., Sieber B.A., Grigoriou M., Kilkenny C., Salazar-Grueso E., Pachnis V., Arumae U. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature. 381:1996;785-789.
38. Wu N., Watkins S.C., Schaffer P.A., DeLuca N.A. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27 and ICP22. J. Virol. 70:1996;6358-6368.
39. Yamada M., Natsume A., Mata M., Oligino T., Goss J., Glorioso J., Fink D.J. Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion. Exp. Neurol. 168:2001;225-230.
40. Yamada M., Oligino T., Mata M., Goss J.R., Glorioso J.C., Fink D.J. Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Proc. Natl. Acad. Sci. USA. 96:1999;4078-4083.
41. Yeung S.N., Tufaro F. Replicating herpes simplex virus vectors for cancer gene therapy. Exp. Opin. Pharmacother. 1:2000;623-631.